Patient engagement in pharmaceutical development

Patient engagement in pharmaceutical development: Where are we? - Report from a symposium

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Patient engagement in pharmaceutical development : Where are we? - Report from a symposium. / Stegemann, Sven; Birna Almarsdóttir, Anna; Vermehren, Charlotte.

I: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Bind 185, 2023, s. 1-4.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Stegemann, S, Birna Almarsdóttir, A & Vermehren, C 2023, 'Patient engagement in pharmaceutical development: Where are we? - Report from a symposium', European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, bind 185, s. 1-4. https://doi.org/10.1016/j.ejpb.2023.02.005

APA

Stegemann, S., Birna Almarsdóttir, A., & Vermehren, C. (2023). Patient engagement in pharmaceutical development: Where are we? - Report from a symposium. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 185, 1-4. https://doi.org/10.1016/j.ejpb.2023.02.005

Vancouver

Stegemann S, Birna Almarsdóttir A, Vermehren C. Patient engagement in pharmaceutical development: Where are we? - Report from a symposium. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2023;185:1-4. https://doi.org/10.1016/j.ejpb.2023.02.005

Author

Stegemann, Sven ; Birna Almarsdóttir, Anna ; Vermehren, Charlotte. / Patient engagement in pharmaceutical development : Where are we? - Report from a symposium. I: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2023 ; Bind 185. s. 1-4.

Bibtex

@article{ac971bccb75b4f738d5672b562a3a8c1,

title = "Patient engagement in pharmaceutical development: Where are we? - Report from a symposium",

abstract = "In recent years, the term {"}patient engagement{"} has found its way into healthcare and specifically into the field of drug development. To better understand the actual status of {"}patient engagement{"} in drug development, a symposium was organized by the Drug Research Academy of the University of Copenhagen (Denmark) on November 16, 2022. The symposium brought together experts from regulatory authorities, industry, academia and patients to share their views and experience of and with patient engagement in drug product development. The symposium led to intensive discussions among the speakers and the audience, confirming that viewpoints and experiences of the different stakeholder provide important input into the promoting patient engagement along the entire drug development life cycle.",

author = "Sven Stegemann and {Birna Almarsd{\'o}ttir}, Anna and Charlotte Vermehren",

year = "2023",

doi = "10.1016/j.ejpb.2023.02.005",

language = "English",

volume = "185",

pages = "1--4",

journal = "European Journal of Pharmaceutics and Biopharmaceutics",

issn = "0939-6411",

publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Patient engagement in pharmaceutical development

T2 - Where are we? - Report from a symposium

AU - Stegemann, Sven

AU - Birna Almarsdóttir, Anna

AU - Vermehren, Charlotte

PY - 2023

Y1 - 2023

N2 - In recent years, the term "patient engagement" has found its way into healthcare and specifically into the field of drug development. To better understand the actual status of "patient engagement" in drug development, a symposium was organized by the Drug Research Academy of the University of Copenhagen (Denmark) on November 16, 2022. The symposium brought together experts from regulatory authorities, industry, academia and patients to share their views and experience of and with patient engagement in drug product development. The symposium led to intensive discussions among the speakers and the audience, confirming that viewpoints and experiences of the different stakeholder provide important input into the promoting patient engagement along the entire drug development life cycle.

AB - In recent years, the term "patient engagement" has found its way into healthcare and specifically into the field of drug development. To better understand the actual status of "patient engagement" in drug development, a symposium was organized by the Drug Research Academy of the University of Copenhagen (Denmark) on November 16, 2022. The symposium brought together experts from regulatory authorities, industry, academia and patients to share their views and experience of and with patient engagement in drug product development. The symposium led to intensive discussions among the speakers and the audience, confirming that viewpoints and experiences of the different stakeholder provide important input into the promoting patient engagement along the entire drug development life cycle.

U2 - 10.1016/j.ejpb.2023.02.005

DO - 10.1016/j.ejpb.2023.02.005

M3 - Journal article

C2 - 36801478

VL - 185

SP - 1

EP - 4

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 336817614